Transapical Transcatheter Treatment of a Stenosed Aortic Valve Bioprosthesis Using the Edwards SAPIEN Transcatheter Heart Valve

Aarhus University Hospital, Aarhus, Central Jutland, Denmark
The Annals of thoracic surgery (Impact Factor: 3.65). 07/2009; 87(6):1943-6. DOI: 10.1016/j.athoracsur.2008.11.034
Source: PubMed

ABSTRACT Transcatheter transapical or transfemoral aortic valve replacement has emerged as an alternative therapy of severe, symptomatic valvular aortic stenosis in surgically nonamenable patients. We report a transapical treatment of a severely stenosed 21-mm aortic Mitroflow valve bioprosthesis (Sorin Group, Vancouver, British Columbia, Canada) in an 82-year-old woman using a 23-mm Edwards SAPIEN Transcatheter Heart Valve ( Edwards Lifesciences, Irvine, CA). (Ann Thorac Surg 2009; 87: 1943-6) (C) 2009 by The Society of Thoracic Surgeons